# Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?

> **NCT00716963** · PHASE4 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 7 (actual)

## Conditions studied

- Mild Intermittent Asthma

## Interventions

- **DRUG:** Fluticasone propionate (Flovent Diskus) 250 mcg
- **DRUG:** budesonide 400 mcg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00716963
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00716963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00716963, "Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00716963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*